SCHEMBL16151237

SCHEMBL16151237

[CH2]C1CCC(=O)NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2187313 0.74
SCHEMBL15918329 0.72
SCHEMBL14749799 0.71
SCHEMBL16139617 0.71
SCHEMBL23343801 0.70
SCHEMBL1707434 0.70
SCHEMBL1559274 0.70
SCHEMBL187229 0.70
SCHEMBL1559273 0.70
SCHEMBL24315889 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103664938-A Benzopyrimidine-containing SYK inhibitor KBP BIOSCIENCES CO LTD 2014-03-26 CN claimed
EP-2970099-A1 SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2016-01-20 EP disclosed
WO-2014164905-A1 SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS ACUCELA INC. (US) 2014-10-09 WO disclosed
CN-103664938-A Benzopyrimidine-containing SYK inhibitor KBP BIOSCIENCES CO LTD 2014-03-26 CN disclosed